| HUMAN-TRIAL | evidence | BPC 157 for Acute Hamstring Muscle Strain Repair | BPC 157 | human-rct · n = 120 | — |
| HUMAN-TRIAL | evidence | PCO-02 - Safety and Pharmacokinetics Trial | BPC 157 | human-rct · n = 42 | — |
| REGULATORY | regulatory | D-0086-2026 — BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute (MHI). | FDA | — | 2025-07-30 |
| REGULATORY | regulatory | D-0085-2026 — BPC-157 for Injection, 15mg/10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Medical Health Institute (MHI), 15mg, 10mL vial lyophilized. | FDA | — | 2025-07-30 |
| REGULATORY | regulatory | D-0776-2022 — BPC-157 2 mg/mL (5 mL) Injection, 5 mL vials, Rx Only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 | FDA | — | 2022-04-05 |
| REGULATORY | regulatory | D-0132-2021 — BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN | FDA | — | 2020-11-30 |
| REGULATORY | regulatory | D-0679-2020 — BPC-157 2000 mcg/mL in 5 mL vials Assurance Infusion (713) 533-8800 | FDA | — | 2019-12-20 |
| REGULATORY | regulatory | D-0459-2019 — BPC 157, 10mg injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684 | FDA | — | 2018-12-17 |
| ANIMAL | evidence | Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia-Reperfusion Injury. | BPC 157 | animal | 2025-02-08 |
| ANIMAL | evidence | Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint. | BPC 157 | Gut barrier & GI healing · animal | 2024-02-01 |
| ANIMAL | evidence | Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect. | BPC 157 | Gut barrier & GI healing · animal | 2023-07-21 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro. | BPC 157 | animal | 2022-12-01 |
| ANIMAL | evidence | Novel insight into Robert's cytoprotection: complex therapeutic effect of cytoprotective pentadecapeptide pentadecapeptide BPC 157 in rats with perforated stomach throughout modulation of nitric oxide-system. Comparison with L-arginine, ranitidine and pantoprazole therapy and L-N(G)-nitro-L-arginine methyl ester worsening. | BPC 157 | animal | 2021-12-01 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia. | BPC 157 | Neuroprotection · animal | 2021-01-01 |
| ANIMAL | evidence | The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats. | BPC 157 | animal | 2020-08-01 |
| ANIMAL | evidence | Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. | BPC157 | Wound healing · animal | 2020-07-01 |
| ANIMAL | evidence | Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric Pentadecapeptide BPC 157. | BPC 157 | Gut barrier & GI healing · animal | 2020-01-01 |
| ANIMAL | evidence | Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME. | BPC 157 | Gut barrier & GI healing · animal | 2019-10-15 |
| ANIMAL | evidence | Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation. | BPC 157 | Inflammation · animal | 2019-03-15 |
| ANIMAL | evidence | Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot. | BPC 157 | animal | 2019-01-01 |
| ANIMAL | evidence | Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine. | BPC 157 | Gut barrier & GI healing · animal | 2018-12-28 |
| ANIMAL | evidence | Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) therapy, to control Nosema ceranae invasions in apiary conditions. | BPC 157 | Gut barrier & GI healing · animal | 2018-08-01 |
| ANIMAL | evidence | Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157. | BPC 157 | animal | 2018-07-01 |
| ANIMAL | evidence | An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system. | BPC 157 | Gut barrier & GI healing · animal | 2018-06-01 |
| ANIMAL | evidence | Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. | BPC 157 | Gut barrier & GI healing · animal | 2017-12-28 |
| ANIMAL | evidence | BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats. | BPC 157 | animal | 2017-10-01 |
| ANIMAL | evidence | Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in rats. | BPC 157 | animal | 2017-04-01 |
| ANIMAL | evidence | Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: L-NAME, L-arginine, stable gastric pentadecapeptide BPC 157. | BPC 157 | Gut barrier & GI healing · animal | 2017-04-01 |
| ANIMAL | evidence | Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME. | BPC 157 | animal | 2016-11-07 |
| ANIMAL | evidence | BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias. | BPC 157 | animal | 2016-06-15 |
| ANIMAL | evidence | Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula. | BPC 157 | Gut barrier & GI healing · animal | 2016-06-05 |
| ANIMAL | evidence | Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats. | BPC 157 | animal | 2016-03-01 |
| ANIMAL | evidence | NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs. | BPC 157 | animal | 2016-01-15 |
| ANIMAL | evidence | Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats. | BPC 157 | animal | 2016-01-01 |
| ANIMAL | evidence | BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental combination. | BPC 157 | Gut barrier & GI healing · animal | 2015-12-01 |
| ANIMAL | evidence | Duodenocutaneous fistula in rats as a model for "wound healing-therapy" in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine. | BPC 157 | animal | 2015-08-01 |
| ANIMAL | evidence | Perforating corneal injury in rat and pentadecapeptide BPC 157. | BPC 157 | animal | 2015-07-01 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. | BPC 157 | animal | 2015-01-01 |
| ANIMAL | evidence | Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. | BPC 157 | animal | 2015-01-01 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. | BPC 157 | Growth hormone axis · animal | 2014-11-19 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration. | BPC 157 | animal | 2014-03-15 |
| ANIMAL | evidence | Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability. | BPC 157 | Gut barrier & GI healing · animal | 2013-10-01 |
| ANIMAL | evidence | Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats. | BPC 157 | animal | 2013-03-12 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy. | BPC 157 | Wound healing · animal | 2013-02-15 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin. | BPC 157 | animal | 2012-05-01 |
| ANIMAL | evidence | Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats. | BPC 157 | animal | 2011-09-30 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions. | BPC 157 | Gut barrier & GI healing · animal | 2011-03-14 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. | BPC 157 | animal | 2010-09-01 |
| ANIMAL | evidence | High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736). | BPC 157 | Gut barrier & GI healing · animal | 2010-04-01 |
| ANIMAL | evidence | Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. | BPC 157 | animal | 2010-03-01 |